3 Notable Runners: Cognizant Technology Solutions Corporation (CTSH), Medtronic plc (MDT), TechnipFMC plc (FTI)

Cognizant Technology Solutions Corporation (CTSH) failed to extend gains with the stock declining -0.05% or $-0.03 to close the day at $58.1 on lower than average trading volume of 4.16M shares, compared to its three month average trading volume of 6.36M. The Teaneck New Jersey 07666 based company has been outperforming the business software & services companies by 7.1588% for last three months and its recent gains have pushed the stock slightly up 3.69% YTD, versus the business software & services industry which is up 3.99% for the same period. The RSI of 61.2 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Cognizant Technology Solutions Corporation provides information technology (IT), consulting, and business process services worldwide. The company operates through four segments: Financial Services, Healthcare, Manufacturing/Retail/Logistics, and Other. Its consulting and technology services include IT strategy consulting, program management consulting, operations improvement consulting, strategy consulting, and business consulting services; and application design and development, systems integration, enterprise resource planning, and customer relationship management implementation services. The company also offers enterprise information management services, such as strategic, advisory, and management consulting; enterprise data management; descriptive analytics/business intelligence; strategic corporate performance management; and packaged analytics services, as well as big data services that assist clients in managing and deriving actionable insights. In addition, it provides application testing services; and develops, licenses, implements, and supports proprietary and third-party software products, as well as offers digital technologies services. Further, the company offers outsourcing services, such as application maintenance services; IT infrastructure services; and business process services, including clinical data management, pharmacovigilance, equity research support, commercial operations, and order management. It serves various industries, including banking and insurance; healthcare and life sciences; manufacturing and logistics; retail, travel, and hospitality; consumer goods; communications; information, media, and entertainment; and technology. The company markets and sells services through its professional staff, senior management, and direct sales personnel. Cognizant Technology Solutions Corporation was founded in 1998 and is headquartered in Teaneck, New Jersey.

Medtronic plc (MDT) had a light trading with around 4.15M shares changing hands compared to its three month average trading volume of 6.67M. The stock traded between $77.16 and $78 before closing at the price of $77.99 with 0.37% change on the day. The Dublin Dublin 2 based company is currently trading 12.46% above its 52 week low of $69.35 and -12.11% below its 52 week high of $89.27. Both the RSI indicator and target price of 70.04 and $84.54 respectively, lead us to believe that it could drop over the coming weeks.

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.

TechnipFMC plc (FTI) traded within a range of $32.28 to $32.78 after opening the day at $32.44. The company has seen its stock decrease in value by -8.58% so far this year. The stock was down close to -0.61% on light volume in last trading session and closed at $32.48 per share. After the recent fall, the stock is currently holding -12.43% below its 52 week high of $37.09 and 40.97% above its 12-month low of $23.27. The shares are down by over -8.25% in the last three months, and the RSI indicator value of 43.25 is neither bullish nor bearish, tempting investors to stay on the sidelines.

TechnipFMC plc provides technologies, systems, and services for oil and gas projects worldwide. It operates in three segments: Subsea, Onshore/Offshore, and Surface Projects. The Subsea segment offers products, such as trees, manifolds, controls, templates, flowline systems, umbilicals, and flexibles, as well as subsea processing products. This segment also provides subsea services, including drilling, installation, completion, and field services, as well as asset management, well intervention and IMR, ROVs, and manipulator system services; and services for subsea projects comprising front end to decommissioning, field architecture, integrated design, engineering, procurement, construction, and installation services. The Onshore/Offshore segment offers technical, technological, and project management services across fixed, floating, and onshore facilities, as well as offshore services. The Surface Projects segment provides drilling, completion, and production wellhead equipment, as well as chokes, compact valves, manifolds, and controls; treating iron, manifolds, and reciprocating pumps for stimulation and cementing; separation and flow-treatment systems; flow metering products and systems; marine, truck, and railcar loading systems; installation maintenance services; frac-stack, manifold rental, and operation services; and flowback and well testing services. The company is headquartered in London, the United Kingdom.

 

3 Stocks to Watch For: Maxim Integrated Products, Inc. (MXIM), Xilinx, Inc. (XLNX), Medtronic plc (MDT)

Maxim Integrated Products, Inc. (MXIM) saw its value decrease by -0.89% as the stock dropped $-0.4 to finish the day at a closing price of $44.63. The stock was lighter in trading and has fluctuated between $31.56-$45.58 per share for the past year. The shares, which traded within a range of $44.57 to $45.13 during the day, are up by 15.57% in the past three months and up by 10.68% over the past six months. It is currently trading 2.58% above its 20 day moving average and 9.02% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $46.35 a share over the next twelve months. The current relative strength index (RSI) reading is 64.02.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Maxim Integrated Products, Inc. designs, develops, manufactures, and markets various linear and mixed-signal integrated circuits in the United States, China, other countries in Asia, Europe, and internationally. It also provides a range of high-frequency process technologies and capabilities for use in custom designs. The company serves automotive, communications and data center, computing, consumer, and industrial markets. It markets its products through a direct-sales and applications organization, as well as through its own and other unaffiliated distribution channels. Maxim Integrated Products, Inc. was founded in 1983 and is headquartered in San Jose, California.

Xilinx, Inc. (XLNX) shares were down in last trading by -1.28% to $58.75. It experienced lighter than average volume on day. The stock increased in value by almost 1.14% over the past week and grew 0.98% in the past month. It is currently trading 1.58% above its 50 day moving average and 14.72% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -5.07% decrease in value from its one year high of $62.24. The RSI indicator value of 54.96, lead us to believe that it is a hold for now.

Xilinx, Inc. designs and develops programmable devices and associated technologies worldwide. Its programmable devices comprise integrated circuits (ICs) in the form of programmable logic devices (PLDs), such as programmable system on chips, and three dimensional ICs; software design tools to program the PLDs; targeted reference designs; printed circuit boards; and intellectual property (IP). The company also offers development boards; development kits, including hardware, design tools, IP, and reference designs that are designed to streamline and accelerate the development of domain-specific and market-specific applications; and configuration products, such as one-time programmable and in-system programmable storage devices to configure field programmable gate arrays. In addition, it provides design services, customer training, field engineering, and technical support. The company offers its products to electronic equipment manufacturers in end markets, such as wired and wireless communications, industrial, scientific and medical, aerospace and defense, audio, video and broadcast, consumer, automotive, and test and measurement. Xilinx, Inc. sells its products through a network of independent distributors; and through direct sales to original equipment manufacturers and electronic manufacturing service providers by a network of independent sales representative firms and by a direct sales management organization. The company was founded in 1984 and is headquartered in San Jose, California.

Medtronic plc (MDT) traded within a range of $76.46 to $77.3 after opening the day at $77. The company has seen its stock increase in value by 8.17% so far this year. The stock was up close to 0.17% on light volume in last trading session and closed at $77.05 per share. After the recent gain, the stock is currently holding -13.17% below its 52 week high of $89.27 and 11.1% above its 12-month low of $69.35. The shares are down by over -5.56% in the last three months, and the RSI indicator value of 65.64 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.

 

Stocks Buzz: Express Scripts Holding Company (ESRX), Medtronic plc (MDT), L Brands, Inc. (LB)

Express Scripts Holding Company (ESRX) managed to rebound with the stock climbing 1.38% or $0.93 to close the day at $68.41 on light trading volume of 3.44M shares, compared to its three month average trading volume of 4.17M. The St. Louis Missouri 63121 based company has been outperforming the health care plans group over the past 52 weeks, with the stock gaining 3.07%, compared to the industry which has advanced 19.65% over the same period. With RSI of 44.25, the stock should still continue to rise and get closer to its one year target estimate of $81.11, making it a hold for now.

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States, Canada, and Europe. The company operates through two segments, PBM and Other Business Operations. The company’s PBM segment’s products and services include clinical solutions to enhance health outcomes; specialized pharmacy care; home delivery pharmacy; specialty pharmacy, including the distribution of fertility pharmaceuticals that require special handling or packaging; and retail network pharmacy administration. It also provides benefit design consultation; drug utilization review; drug formulary management; an array of Medicare, Medicaid, and health insurance marketplace; administration of a group purchasing organization; and consumer health and drug information services. In addition, the company distributes specialty pharmaceuticals and medical supplies to providers, clinics, and hospitals; and offers consulting services, including design, implementation, and project management for pharmaceutical, biotechnology, and device manufacturers to collect scientific evidence to guide the use of medicines. It serves managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans, government health programs, providers, clinics, hospitals, and others. As of December 31, 2015, the company operated four automated dispensing home delivery pharmacies; one non-automated dispensing home delivery pharmacy; and one non-dispensing home delivery pharmacy maintained for business continuity purpose, as well as several non-dispensing order processing centers, patient contact centers, specialty drug pharmacies, and fertility pharmacies. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in St. Louis, Missouri.

Medtronic plc (MDT) grew with the stock adding 0.58% or $0.44 to close at $76.15 on light trading volume of 3.43M compared its three months average trading volume of 6.92M. The Dublin Dublin 2 based company operating under the Medical Appliances & Equipment industry has been trending up for the last 52 weeks, with the shares price now 6.55% up for the period and up by 6.91% so far this year. With price target of $84.54 and a 9.81% rebound from 52-week low, Medtronic plc has plenty of upside potential, making it a hold with a view buy.

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.

L Brands, Inc. (LB) managed to rebound with the stock declining 0% or $0 to close the day at $58.92 on higher than average trading volume of 3.35M shares, compared to its three month average trading volume of 2.43M. The Columbus Ohio 43230 based company has been underperforming the apparel stores companies by -10.569% for last three months and its recent losses have pulled the stock down -10.51% YTD, versus the apparel stores industry which is down -1.18% for the same period. The RSI of 33.69 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

L Brands, Inc. operates as a specialty retailer of women’s intimate and other apparel, beauty and personal care products, and accessories. The company operates in three segments: Victoria’s Secret, Bath & Body Works, and Victoria’s Secret and Bath & Body Works International. Its products include loungewear, bras, panties, swimwear, athletic attire, fragrances, shower gels and lotions, aromatherapy, soaps and sanitizers, home fragrances, handbags, jewelry, and personal care accessories. The company offers its products under the Victoria’s Secret, Pink, Bath & Body Works, La Senza, Henri Bendel, C.O. Bigelow, White Barn Candle Company, and other brand names. L Brands, Inc. sells its merchandise through company-owned specialty retail stores in the United States, Canada, and the United Kingdom, which are primarily mall-based; through its Websites; and through franchises, licenses, and wholesale partners. As of January 31, 2016, the company operated 2,721 retail stores in the United States; 270 retail stores in Canada; and 14 retail stores in the United Kingdom. It also operated 221 La Senza stores in 29 countries; 125 Bath & Body Works stores in 30 countries; 19 Victoria’s Secret stores in 7 Middle Eastern countries; and 373 Victoria’s Secret Beauty and Accessories stores, and various small-format locations in approximately 75 countries. The company was formerly known as Limited Brands, Inc. and changed its name to L Brands, Inc. in March 2013. L Brands, Inc. was founded in 1963 and is headquartered in Columbus, Ohio.

 

Worth Watching Stocks: D.R. Horton, Inc. (DHI), Medtronic plc (MDT), CBS Corporation (CBS)

D.R. Horton, Inc. (DHI) saw its value increase by 1.6% as the stock gained $0.47 to finish the day at a closing price of $29.89. The stock was lighter in trading and has fluctuated between $23.01-$34.56 per share for the past year. The shares, which traded within a range of $29.37 to $29.93 during the day, are up by 2.47% in the past three months and down by -6.74% over the past six months. It is currently trading 1.69% above its 20 day moving average and 4.58% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $34.3 a share over the next twelve months. The current relative strength index (RSI) reading is 54.89.The technical indicator lead us to believe there will be no major movement any time soon, hold.

D.R. Horton, Inc. operates as a homebuilding company. It engages in the acquisition and development of land; and construction and sale of homes in 26 states and 78 markets in the United States under the names of D.R. Horton, America’s Builder, Express Homes, Emerald Homes, Regent Homes, Crown Communities, and Pacific Ridge Homes. The company constructs and sells single-family detached homes; and attached homes, such as town homes, duplexes, triplexes, and condominiums. It is also involved in the origination and sale of mortgages; and provision of title insurance policies, and examination and closing services. The company primarily serves title insurance agents, homebuyers, and homebuilding customers. D.R. Horton, Inc. was founded in 1978 and is headquartered in Fort Worth, Texas.

Medtronic plc (MDT) shares were down in last trading by -0.68% to $75.6. It experienced lighter than average volume on day. The stock decreased in value by almost -0.53% over the past week and grew 2.41% in the past month. It is currently trading 2.73% above its 50 day moving average and -7.31% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -15.31% decrease in value from its one year high of $89.27. The RSI indicator value of 57.45, lead us to believe that it is a hold for now.

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.

CBS Corporation (CBS) traded within a range of $63.24 to $64.47 after opening the day at $64.47. The company has seen its stock decrease in value by -0.17% so far this year. The stock was down close to -1.49% on light volume in last trading session and closed at $63.51 per share. After the recent fall, the stock is currently holding -5.04% below its 52 week high of $66.88 and 55.44% above its 12-month low of $41.9. The shares are up by over 10.55% in the last three months, and the RSI indicator value of 47.14 is neither bullish nor bearish, tempting investors to stay on the sidelines.

CBS Corporation operates as a mass media company worldwide. The company’s Entertainment segment distributes a schedule of news and public affairs broadcasts, and sports and entertainment programming; produces, acquires, and distributes programming, including series, specials, news, and public affairs; operates online content networks for information and entertainment; and produces, acquires, and distributes theatrical motion pictures. Its Cable Networks segment offers subscription program services, such as original series, theatrical feature films, documentaries, boxing and other sports-related programming, and special events; and owns and operates multiplexed channels. This segment also owns and manages Smithsonian Networks, which operates a channel featuring cultural, historical, scientific, and educational programs; and operates a CBS Sports Network, a 24-hour cable program service that provides college sports and related content. The company’s Publishing segment publishes and distributes adult and children’s consumer books in printed, digital, and audio formats; and develops special imprints and publishes titles based on the products, as well as that of third parties and distributes products for other publishers. This segment also delivers content; and promotes its products on its Websites, social media, and general Internet sites, as well as those related to individual titles. Its Local Broadcasting segment owns 30 broadcast television stations; owns and operates 117 radio stations in 26 U.S. markets and related online properties; and operates local digital properties in various U.S. markets that combine the company’s television and radio local media brands online to offer the latest news, traffic, weather, and sports information, as well as local discounts, directories, and reviews for local community. The company was founded in 1986 and is headquartered in New York, New York. CBS Corporation is a subsidiary of National Amusements, Inc.

 

Stocks Buzz: Medtronic plc (MDT), Occidental Petroleum Corporation (OXY), T-Mobile US, Inc. (TMUS)

Medtronic plc (MDT) failed to extend gains with the stock declining -0.47% or $-0.36 to close the day at $75.98 on light trading volume of 3.78M shares, compared to its three month average trading volume of 7.06M. The company has been outperforming the medical appliances & equipment group over the past 52 weeks, with the stock gaining 3.07%, compared to the industry which has advanced 18.15% over the same period. With RSI of 61.64, the stock should still continue to rise and get closer to its one year target estimate of $84.54, making it a hold for now.

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.

Occidental Petroleum Corporation (OXY) retreated with the stock falling -1.43% or $-0.99 to close at $68.19 on light trading volume of 3.78M compared its three months average trading volume of 4.9M. The Houston Texas 77046 based company operating under the Independent Oil & Gas industry has been trending up for the last 52 weeks, with the shares price now 8.53% up for the period and down by -4.27% so far this year. With price target of $76.88 and a 12.36% rebound from 52-week low, Occidental Petroleum Corporation has plenty of upside potential, making it a hold with a view buy.

Occidental Petroleum Corporation engages in the acquisition, exploration, and development of oil and gas properties in the United States and internationally. The company operates in three segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops, and produces oil and condensate, natural gas liquids (NGLs), and natural gas. The Chemical segment manufactures and markets basic chemicals, including chlorine, caustic soda, chlorinated organics, potassium chemicals, ethylene dichloride, chlorinated isocyanurates, sodium silicates, and calcium chloride; vinyls comprising vinyl chloride monomer and polyvinyl chloride; and other chemicals, such as resorcinol. The Midstream and Marketing segment gathers, processes, transports, stores, purchases, and markets oil, condensate, NGLs, natural gas, carbon dioxide, and power. This segment also trades around its assets consisting of transportation and storage capacity, as well as oil, NGLs, gas, and other commodities. Occidental Petroleum Corporation was founded in 1920 and is headquartered in Houston, Texas.

T-Mobile US, Inc. (TMUS) failed to extend gains with the stock declining -0.65% or $-0.4 to close the day at $60.96 on lower than average trading volume of 3.76M shares, compared to its three month average trading volume of 4.1M. The Bellevue Washington 98006 based company has been outperforming the wireless communications companies by 23.0479% for last three months and its recent gains have pushed the stock slightly up 6% YTD, versus the wireless communications industry which is up 5.93% for the same period. The RSI of 55.17 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

T-Mobile US, Inc., together with its subsidiaries, provides mobile communications services for consumers and businesses in the United States, Puerto Rico, and the U.S. Virgin Islands. The company offers voice, messaging, and data services in the postpaid, prepaid, and wholesale markets. It also provides wireless devices, including smartphones, tablets, and other mobile communication devices, as well as accessories that are manufactured by various suppliers. The company offers services, devices, and accessories under the T-Mobile and MetroPCS brands through its owned and operated retail stores, as well as through its Websites. T-Mobile US, Inc. also sells its devices and accessories to dealers and other third party distributors for resale through independent third-party retail outlets and various third-party Websites. It delivers wireless services to approximately 65.5 million customers. The company was founded in 1994 and is headquartered in Bellevue, Washington. T-Mobile US, Inc. operates as a subsidiary of Deutsche Telekom Holding B.V.

 

Traders Recap: ONEOK, Inc. (OKE), The Bank of New York Mellon Corporation (BK), Medtronic plc (MDT)

ONEOK, Inc. (OKE) managed to rebound with the stock climbing 2.89% or $1.56 to close the day at $55.56 on higher than average trading volume of 5.38M shares, compared to its three month average trading volume of 2.15M. The Tulsa Oklahoma 74103 based company has been outperforming the gas utilities companies by 15.6743% for last three months and its recent gains have offset losses to -2.14% YTD, versus the gas utilities industry which is up 1.2% for the same period. The RSI of 50.8 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

ONEOK, Inc., through its general partner interests in ONEOK Partners, L.P., engages in the gathering, processing, storage, and transportation of natural gas in the United States. It operates through the Natural Gas Gathering and Processing, the Natural Gas Liquids, and the Natural Gas Pipelines segments. The company gathers, treats, fractionates, stores, and transports natural gas liquids (NGL), as well as owns natural gas liquids gathering and distribution pipelines, natural gas liquids distribution and refined petroleum products pipelines, and terminal and storage facilities; and operates interstate and intrastate regulated natural gas transmission pipelines and natural gas storage facilities, as well as stores, markets, and distributes NGL products to petrochemical manufacturers, heating fuel users, ethanol producers, refineries, exporters, and propane distributors. It also owns and operates a parking garage in downtown Tulsa, Oklahoma; and leases excess office space to others. ONEOK, Inc. was founded in 1906 and is headquartered in Tulsa, Oklahoma.

The Bank of New York Mellon Corporation (BK) had a light trading with around 5.36M shares changing hands compared to its three month average trading volume of 6.5M. The stock traded between $44.5 and $45.08 before closing at the price of $44.8 with -0.49% change on the day. The New York New York 10286 based company is currently trading 41.6% above its 52 week low of $32.2 and -9.18% below its 52 week high of $49.54. Both the RSI indicator and target price of 38.46 and $52.11 respectively, lead us to believe that it should be put on hold over the coming weeks.

The Bank of New York Mellon Corporation, an investment company, provides financial products and services to institutions, corporations, and high net worth individuals in the United States and internationally. It operates through two segments, Investment Management and Investment Services. The company offers investment management; trust and custody; foreign exchange; fund administration; global collateral services; securities lending; depositary receipts; corporate trust; global payment/cash management; banking services; and clearing services. It also provides mutual funds, separate accounts, wealth management and private banking services; and broker-dealer services, registered investment advisory services, prime brokerage services, and working capital solutions. In addition, the company is involved in credit-related activities, business exits, leasing operations, and corporate treasury activities; and the provision of global markets and institutional banking services. The Bank of New York Mellon Corporation was founded in 1784 and is headquartered in New York, New York.

Medtronic plc (MDT) traded within a range of $75.44 to $76.29 after opening the day at $75.58. The company has seen its stock increase in value by 6.58% so far this year. The stock was down close to -0.11% on light volume in last trading session and closed at $75.92 per share. After the recent fall, the stock is currently holding -14.45% below its 52 week high of $89.27 and 9.47% above its 12-month low of $69.35. The shares are down by over -5.62% in the last three months, and the RSI indicator value of 63.47 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.

 

Stock’s Trend Analysis Report: Medtronic plc (MDT), Charter Communications, Inc. (CHTR), The Procter & Gamble Company (PG)

Medtronic plc (MDT) climbed 1.81% during last trading as the stock added $1.35 to finish the day at $76.02 with about 7.81M shares changing hands, compared to its three month average trading volume of 7.05M. The $104.38B market cap company, which fluctuated between $74.27 and $76.23 during the day, currently situated 9.62% above its 52 week low of $69.35 and -14.33% away from its one year high of $89.27. The RSI of 63.39 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.

Charter Communications, Inc. (CHTR) dropped $-0.85 to close the day at a new closing price of $323.95, a -0.26% decrease in value from its previous closing price that moved the stock 107.49% above its 52 week low of $156.13. A total of 1.01M shares exchanged hands during the day compared with its three month average trading volume of 1.99M. The stock, which fluctuated between $321.03 and $325.27 during the day, currently situated -5.14% below its 52 week high. The stock is up by 10.87% in the past one month and up by 29.97% over the past three months. With a one year target estimate of $0 and RSI of 69.71, the stock still has upside potential, making it a hold for now.

Charter Communications, Inc., through its subsidiaries, provides cable services in the United States. The company offers various entertainment, information, and communications solutions to residential and commercial customers. Its video service offerings include a package of basic video programming, video on demand, subscription on demand, pay-per-view, high definition television, digital video recorder, Spectrum TV app on mobile devices, Spectrum TV app on immobile devices, and Spectrum guide services. The company also provides Internet services, such as residential Internet services; Charter.net, an Internet portal that provides multiple e-mail addresses; and Charter Security Suite that protects computers from viruses and spyware, as well as offers parental control features. In addition, it offers voice communications services using voice over Internet protocol technology; and broadband communications solutions, such as Internet access, data networking, fiber connectivity, video entertainment, and business telephone services to cellular towers and office buildings for business and carrier organizations. Further, the company sells local advertising on digital advertising networks and satellite-delivered networks. As of December 31, 2015, it served approximately 6.7 million residential, and small and medium business customers; approximately 4.3 million residential video customers; approximately 5.2 million residential Internet customers; approximately 2.6 million residential voice service customers; and approximately 671,000 small and medium business primary service units (PSUs) and 30,000 enterprise PSUs. Charter Communications, Inc. was founded in 1999 and is headquartered in Stamford, Connecticut.

The Procter & Gamble Company (PG) had a active trading with around 9.69M shares changing hands compared to its three month average trading volume of 9.17M. The stock traded between $86.53 and $87.66 before closing at the price of $87.6 with 0.98% change on the day. The Cincinnati Ohio 45202 based company is currently trading 13.53% above its 52 week low of $79.1 and -1.5% below its 52 week high of $90.33. Both the RSI indicator and target price of 67.5 and $90.53 respectively, lead us to believe that it should be put on hold over the coming weeks.

The Procter & Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, India, the Middle East, Africa, and Latin America. The company’s Beauty segment offers hair care products comprising conditioners, shampoos, styling aids, and treatments; and antiperspirants and deodorants, personal cleansing, and skin care products. This segment markets its products under the Head & Shoulders, Olay, Pantene, Rejoice, Old Spice, Safeguard, and SK-II brands. Its Grooming segment provides blades and razors, pre- and post-shave products, and other shave care products, as well as appliances under the Braun, Fusion, Gillette, Mach3, Prestobarba, and Venus brands. The company’s Health Care segment offers toothbrushes, toothpaste, and other oral care products; and gastrointestinal, rapid diagnostics, respiratory, vitamins/minerals/supplements, and other healthcare products under the Oral-B, Crest, Prilosec, Vicks, Metamucil, Pepto Bismol, and Align brands. Its Fabric & Home Care segment provides fabric care products, including fabric enhancers, laundry additives, and laundry detergents; and home care products comprising air care, dish care, P&G professional, and surface care products under the Tide, Ariel, Downy, Gain, Cascade, Dawn, Febreze, Mr. Clean, and Swiffer brands. The company’s Baby, Feminine & Family Care segment offers baby care products, such as baby wipes, diapers, and pants; adult incontinence and feminine care products; and family care products, such as paper towels, tissues, and toilet papers. This segment markets its products under the Pampers, Always, Bounty, Charmin, Luvs, and Tampax brands. The company sells its products through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, distributors, baby stores, specialty beauty stores, e-commerce, high-frequency stores, and pharmacies. The Procter & Gamble Company was founded in 1837 and is based in Cincinnati, Ohio.

 

Stocks In Action: Amgen Inc. (AMGN), The Boeing Company (BA), Medtronic plc (MDT)

Amgen Inc. (AMGN) traded within a range of $152.76 to $157.5 after opening the day at $153.23. The company has seen its stock increase in value by 7.49% so far this year. The stock was up close to 2.73% on active volume in last trading session and closed at $157.16 per share. After the recent gain, the stock is currently holding -10.53% below its 52 week high of $176.85 and 18.39% above its 12-month low of $133.64. The shares are down by over -0.48% in the last three months, and the RSI indicator value of 60.81 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of illness in the areas of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience. The company’s products include Neulasta, a pegylated protein for the treatment of cancer patients; NEUPOGEN, a recombinant-methionyl human granulocyte colony-stimulating factor for reducing the incidence of infection for patients with non-myeloid malignancies; and Enbrel to treat rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis. Its products also comprise EPOGEN to treat a lower-than-normal number of red blood cells caused by chronic kidney disease (CKD) in patients on dialysis; Aranesp for treating anemia; XGEVA for the prevention of skeletal-related events; Prolia to treat postmenopausal women with osteoporosis; Repatha for the treatment of cholesterol; and Sensipar/Mimpara products for use in the treatment of secondary hyperparathyroidism in CKD patients on dialysis. The company’s other marketed products include Kyprolis, a proteasome inhibitor to treat patients with multiple myeloma and small-cell lung cancer; Nplate, a thrombopoietic compound; Vectibix, a human monoclonal antibody; and BLINCYTO for the treatment of patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia. It also develops various products that are in various clinical trials. The company serves pharmaceutical wholesale distributors; and physicians or their clinics, dialysis centers, hospitals, and pharmacies, as well as consumers. It has collaborative agreements with Xencor, Inc; UCB; Novartis AG; Bayer HealthCare Pharmaceuticals Inc; Advaxis, Inc.; Dr. Reddy’s Laboratories Ltd.; Biocartis Group NV; and Nuevolution AB. The company also has a strategic collaboration with Immatics Biotechnologies GmbH. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

The Boeing Company (BA) failed to extend gains with the stock declining -0.84% or $-1.42 to close the day at $167.7 on active trading volume of 4.88M shares, compared to its three month average trading volume of 3.34M. The Chicago Illinois 60606 based company has been outperforming the aerospace/defense products & services group over the past 52 weeks, with the stock gaining 46.91%, compared to the industry which has advanced 33.57% over the same period. With RSI of 73.26, the stock should still continue to rise and get closer to its one year target estimate of $168.75, making it a hold for now.

The Boeing Company, together with its subsidiaries, designs, develops, manufactures, sells, services, and supports commercial jetliners, military aircraft, satellites, missile defense, human space flight, and launch systems and services worldwide. The company operates in five segments: Commercial Airplanes, Boeing Military Aircraft, Network & Space Systems, Global Services & Support, and Boeing Capital. The Commercial Airplanes segment develops, produces, and markets commercial jet aircraft for various passenger and cargo requirements, as well as provides related support services to the commercial airline industry. This segment also offers aviation services support, aircraft modifications, spare parts, training, maintenance documents, and technical advice to commercial and government customers. The Boeing Military Aircraft segment is involved in the research, development, production, and modification of manned and unmanned military aircraft and weapons systems for the global strike, vertical lift, and autonomous systems, as well as mobility, surveillance, and engagement. The Network & Space Systems segment engages in the research, development, production, and modification of electronics and information solutions; strategic missile and defense systems; space and intelligence systems; and space exploration products. The Global Services and Support segment offers integrated logistics, including supply chain management and engineering support; maintenance, modification, and upgrades for aircraft; and training systems and government services, such as pilot and maintenance training. The Boeing Capital segment facilitates, arranges, structures, and provides financing solutions, such as equipment under operating leases, finance leases, notes and other receivables, assets held for sale or re-lease, and investments. The Boeing Company was founded in 1916 and is headquartered in Chicago, Illinois.

Medtronic plc (MDT) gained $0.91 to close the day at a new closing price of $74.95, a 1.23% increase in value from its previous closing price that moved the stock 8.07% above its 52 week low of $69.35. A total of 4.88M shares exchanged hands during the day compared with its three month average trading volume of 7.03M. The stock, which fluctuated between $74.47 and $75.23 during the day, currently situated -15.54% below its 52 week high. The stock is up by 4.43% in the past one month and down by -7.05% over the past three months. With a one year target estimate of $84.54 and RSI of 57.39, the stock still has upside potential, making it a hold for now.

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.

 

Trader’s Round Up: MGM Resorts International (MGM), Medtronic plc (MDT), Occidental Petroleum Corporation (OXY)

MGM Resorts International (MGM) grew with the stock adding 2.03% or $0.59 to close at $29.6 on light trading volume of 6.17M compared its three months average trading volume of 7.59M. The Las Vegas Nevada 89109 based company operating under the Resorts & Casinos industry has been trending up for the last 52 weeks, with the shares price now 54.89% up for the period and up by 2.67% so far this year. With price target of $34.58 and a 82.94% rebound from 52-week low, MGM Resorts International has plenty of upside potential, making it a hold with a view buy.

MGM Resorts International, through its wholly owned subsidiaries, owns and/or operates casino resorts in the United States and China. The company operates through two segments, Wholly Owned Domestic Resorts and MGM China. Its casino resorts offer gaming, hotel, convention, dining, entertainment, retail, and other resort amenities. Its casino operations include various slots, table games, and race and sports book wagering. The company operates 12 wholly owned resorts in the United States; and MGM Macau resort and casino in China, as well as develops an integrated casino, hotel, and entertainment resort on the Cotai Strip, Macau. The company also owns and operates Shadow Creek golf course, Primm Valley Golf Club, and Fallen Oak golf course. The company serves premium gaming customers; leisure and wholesale travel customers; business travelers; and group customers, including conventions, trade associations, and small meetings. The company was formerly known as MGM MIRAGE and changed its name to MGM Resorts International in June 2010. MGM Resorts International was founded in 1986 and is based in Las Vegas, Nevada.

Medtronic plc (MDT) gained $0.66 to close the day at a new closing price of $74.49, a 0.89% increase in value from its previous closing price that moved the stock 7.41% above its 52 week low of $69.35. A total of 6.17M shares exchanged hands during the day compared with its three month average trading volume of 7.01M. The stock, which fluctuated between $73.59 and $74.61 during the day, currently situated -16.06% below its 52 week high. The stock is up by 3.83% in the past one month and down by -10.04% over the past three months. With a one year target estimate of $84.54 and RSI of 53.39, the stock still has upside potential, making it a hold for now.

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.

Occidental Petroleum Corporation (OXY) shares were up in last trading by 0.38% to $68.13. It experienced higher than average volume on day. The stock decreased in value by almost -1.72% over the past week and fell -5.85% in the past month. It is currently trading -2.31% below its 50 day moving average and -5.64% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -11.59% decrease in value from its one year high of $78.48. The RSI indicator value of 38.34, lead us to believe that it is a hold for now.

Occidental Petroleum Corporation engages in the acquisition, exploration, and development of oil and gas properties in the United States and internationally. The company operates in three segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops, and produces oil and condensate, natural gas liquids (NGLs), and natural gas. The Chemical segment manufactures and markets basic chemicals, including chlorine, caustic soda, chlorinated organics, potassium chemicals, ethylene dichloride, chlorinated isocyanurates, sodium silicates, and calcium chloride; vinyls comprising vinyl chloride monomer and polyvinyl chloride; and other chemicals, such as resorcinol. The Midstream and Marketing segment gathers, processes, transports, stores, purchases, and markets oil, condensate, NGLs, natural gas, carbon dioxide, and power. This segment also trades around its assets consisting of transportation and storage capacity, as well as oil, NGLs, gas, and other commodities. Occidental Petroleum Corporation was founded in 1920 and is headquartered in Houston, Texas.

 

3 Stocks to Watch For: Aetna Inc. (AET), Medtronic plc (MDT), Groupon, Inc. (GRPN)

Aetna Inc. (AET) saw its value decrease by -1.33% as the stock dropped $-1.59 to finish the day at a closing price of $117.61. The stock was higher in trading and has fluctuated between $92.42-$136.5 per share for the past year. The shares, which traded within a range of $116.56 to $118.94 during the day, are up by 5.93% in the past three months and up by 0.23% over the past six months. It is currently trading -4.48% below its 20 day moving average and -6.06% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $140.07 a share over the next twelve months. The current relative strength index (RSI) reading is 29.42.The technical indicator lead us to believe the stock will reverse recent losses any time soon.

Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management services, dental, behavioral health, and vision plans on an insured basis, as well as an employer-funded or administrative services contract basis. It also provides point-of-service, preferred provider organization, health maintenance organization, and indemnity benefit plans, as well as health savings accounts and consumer-directed health plans. In addition, this segment offers Medicare and Medicaid products and services, as well as other medical products, such as medical management and data analytics services, medical stop loss insurance, workers’ compensation administrative services, and products that provide access to its provider networks in select geographies. The Group Insurance segment offers life insurance products, including group term life insurance, voluntary spouse and dependent term life insurance, group universal life insurance, and accidental death and dismemberment insurance; disability insurance products; and long-term care insurance products, which provide the benefits to cover the cost of care in private home settings, adult day care, assisted living, or nursing facilities. The Large Case Pensions segment manages retirement products, including pension and annuity products primarily for tax-qualified pension plans. The company offers its products to employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Aetna Inc. has a collaboration agreement with Commonwealth Health to introduce a new health plan; and Regional Cancer Care Associates to create an oncology medical home. The company was founded in 1853 and is based in Hartford, Connecticut.

Medtronic plc (MDT) shares were down in last trading by -1.26% to $73.83. It experienced lighter than average volume on day. The stock decreased in value by almost -2.62% over the past week and grew 3.14% in the past month. It is currently trading -0.72% below its 50 day moving average and -9.1% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -16.8% decrease in value from its one year high of $89.27. The RSI indicator value of 50.97, lead us to believe that it is a hold for now.

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.

Groupon, Inc. (GRPN) traded within a range of $3.43 to $3.5 after opening the day at $3.48. The company has seen its stock increase in value by 5.12% so far this year. The stock was up close to 0.58% on light volume in last trading session and closed at $3.49 per share. After the recent gain, the stock is currently holding -41.25% below its 52 week high of $5.94 and 62.33% above its 12-month low of $2.15. The shares are down by over -30.48% in the last three months, and the RSI indicator value of 42.42 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Groupon, Inc. operates online local commerce marketplaces that connect merchants to consumers by offering goods and services at a discount in North America, Europe, the Middle East, Africa, and internationally. It also provides deals on products for which it acts as the merchant of record. The company offers deals in various categories, including food and drink, events and activities, beauty and spa, health and fitness, home and garden, and automotive; and deals on various product lines, such as electronics, sporting goods, jewelry, toys, household items, and apparel, as well as provides discounted and market rates for hotel, airfare, and package deals. It offers its deal offerings to customers through Websites; search engines; and mobile applications and mobile browsers, which enable consumers to browse, purchase, manage, and redeem deals on their mobile devices, as well as sends emails to its subscribers with deal offerings that are targeted by location and personal preferences. The company was formerly known as ThePoint.com, Inc. and changed its name to Groupon, Inc. in October 2008. The company was founded in 2008 and is headquartered in Chicago, Illinois. Groupon, Inc. is a subsidiary of The Point, LLC.